drugset / Trial / NCT00814125
ATAC - Endometrial Sub-Protocol
RandomizedParallel-groupDouble-blind
Summary
To compare the difference between the ARIMIDEX group and the tamoxifen group in the incidence of abnormal endometrial histological findings arising after treatment has commenced.
Timeline
- Start
- 1997-06
- Primary completion
- —
- Completion
- 2005-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Anastrozole | Other / unclassified | 1 mg | Oral |
| Comparator | Tamoxifen | Small molecule | 20 mg | Oral |